Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria

Tropical Medicine and International Health

Volumn 9, Issue 2, 2004, Pages 200-208

  Abacassamo, F ^a,b   Enosse, S ^a,c   Aponte, J J ^a,d   Gomez Olive F X ^a,d   Quinto L ^a,d   Mabunda, S ^e   Barreto, A ^e   Magnussen, P ^f   Ronn A M ^g   Thompson, R ^a,b,c   Alonso, P L ^a,d  

^a Ctro Investigacao Saude da Manhica   (Mozambique)

^b EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^c INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^d HOSPITAL CLÍNIC   (Spain)

^e National Malaria Control Programme   (Mozambique)

^f DANISH BILHARZIASIS LABORATORY   (Denmark)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antimalarials; Combination therapy; Drug resistance; First line treatment; National policy; Plasmodium falciparum

Indexed keywords

AMODIAQUINE; ARTESUNATE; CHLOROQUINE; FANSIDAR;

DISEASE TREATMENT; DRUG PRESCRIBING; DRUG RESISTANCE; MALARIA;

ARTICLE; BODY TEMPERATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FEMALE; FOLLOW UP; GAMETOCYTE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MOZAMBIQUE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; VOMITING; WORLD HEALTH ORGANIZATION;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MOZAMBIQUE; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME;

AFRICA; MOZAMBIQUE; SOUTHERN AFRICA; SUB-SAHARAN AFRICA;

ARTESUNATE; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 10744232839     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2003.01182.x     Document Type: Article

References (34)

1. Alonso PL, Smith T & Armstrong Schellemberg JRM (1994) Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344, 1175-1181.
2. Basco LK, Tahar R & Ringwald P (1998) Molecular basis of in vivo resistance to sulfadoxine/pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites. Antimicrobial Agents Chemotherapy 42, 1811-1814.
3. Bloland PB, Ettling M & Meek S (2000) Combination therapy for malaria in Africa: hype or hope? Bulletin of the World Health Organization 78, 1378-1388.
4. Brasseur P, Guiguembe R, Diallo S et al. (1999) Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 645-650.
5. Dgedge M, Streat E, Mabunda S et al. (1997) Resistência in vivo e in vitro do P. falciparum a Cloroquina e sua eficácia terapêutica no tratamento da malária em Moçambique. Revista medica de Moçambique 7, 12-16.
6. Dgedge M, Mabunda S, Enosse S & Streat E (1998) Avaliacao in vivo da eficácia terapêutica e da sensibilidade do P. falciparum a Cloroquina e sulfadoxina-pirimethamina no tratamento da malária não complicada em Moçambique. Ministério da Saúde, Maputo, Mozambique (relatorio final 48 pg).
7. Dillen JV, Custers M, Wensink A et al. (1999) A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 185-188.
8. Doherty JF, Sadiq AD, Bayo L et al. (1999) A randomized safety and tolerability trial of artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 543-546.
9. Dorsey G, Njama D, Kamya MR et al. (2002) Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomized trial. The Lancet 360, 2031-2038.
10. Enosse S, Mabunda S & Thompson R (2001) Sensibilidade In vivo e prevalencia de marcadores geneticos da resistencia do Plasmodium falciaprum a sulfadoxina-pirimetamina no decurso de uma Epidemia de malaria no sul de Moçambique. XI Jornadas de Saúde, abstract book. p. 67.
11. Franco ALT, Schwalback J, Fernandes A & Schapira A. (1984) Existencia em Mocambique de malaria P. falciparum resistente a cloroquina (1983-1984). Revista medica de Mocambique 2, 83-85.
12. Gorissen E, Ashruf G, Lamboo M et al. (2000) In vivo efficacy study of amodiaquine and sulfadoxine/pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania. Tropical Medicine and International Health 5, 459-463.
13. Loscertales MP, Roca A, Ventura PJ et al. (2002) Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique. The Pediatric Infectious Disease Journal 21, 148-155.
14. Mayor AG, Gómez-Olivé X, Aponte JJ et al. (2001) Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. The Journal of Infectious Diseases 183, 1413-1416.
15. Nzila AM, Nduati E, Mberu K et al. (2000) Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulfadoxine compared with the shorter-acting chlorproguanil/ dapsone on Kenyan Plasmodium falciparum. The Journal of Infectious Diseases 181, 2023-2028.
16. Olliaro P, Nevill C, LeBras J et al. (1996) Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348, 1196-1201.
17. Plowe CV, Cortese JF, Djimde A et al. (1997) Mutations in Plasmodium falciparum dihydrofolate reductase, dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. Journal of Infectious Diseases 176, 1590-1596.
18. Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH & Bygbjerg IC (1996) High level of resistance of Plasmodium falciparum to sulfadoxine/pyrimethamine in children in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 179-181.
19. Rwagacondo CE, Niyitegeka F, Sarushi J et al. (2003) Efficacy of amodiaquine alone and combined with sulfadoxine pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate. American Journal of Tropical Medicine and Hygiene 68, 743-747.
20. Saúte F, Aponte J, Almeda J et al. (2003) Malaria in southern Mozambique: incidence of clinical malaria in children living in a rural community in Manhiça district. Transactions of the Royal Society of Tropical Medicine and Hygiene (in press).
21. Schapira A & Schwalback JFL (1988) Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986. Bulletin of the World Health Organization 66, 219-226.
22. Schapira A & Schwalback J (1989) A malaria resistente em Mocambique. Epidemiologia e control 1983-1987. Instituto Nacional de Saude, Maputo.
23. Schellenberg D, Kahigwa E, Drakeley C et al. (2002) The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. American Journal of Tropical Medicine and Hygiene 67, 17-23.
24. Seidlein Lv, Milligan P, Pinder M et al. (2000) Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomized, controlled trial. Lancet 355, 352-357.
25. Seidlein Lv, Jawara M, Coleman R, Doherty T, Walraven G & Targett G (2001) Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Tropical Medicine and International Health 6, 92-98.
26. Sibley CH, Hyde JE, Sims PFG et al. (2001) Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends in Parasitology 17, 582-588.
27. Staedke SG, Kamya MR, Dorsey G et al. (2001) Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomized trial. Lancet 358, 368-374.
28. TaKecki M, Matsuo M, Ziba C et al. (2001) Therapeutic efficacy of sulphadoxine/pyrimethamine and susceptibility in vitro of Plasmodium falciparum isolates to sulphadoxine-pyrimethamine and other antimalarial drugs in Malawian children. Tropical Medicine and International Health 6, 429-434.
29. Targett G, Drakeley C, Jawara M et al. (2001) Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. The Journal of Infectious Disease 183, 1254-1259.
30. Thompson R (1999) The microepidemiology of malaria in Matola, a periurban area of Maputo, Mozambique. PhD Thesis, Faculty of Health Sciences, University of Aarhus, Denmark.
31. Watkins WH & Mosobo M (1993) Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selection pressure for resistance is a function of long elimination half-life. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 75-78.
32. White N (1999) Antimalarial drug resistance and combination chemotherapy. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 354, 739-749.
33. WHO (1994) Antimalarial Drug Polices: Data Requirements, Treatment of Uncomplicated Malaria in Pregnancy. Division of Control of Tropical Disease, World Health Organization, Geneva.
34. WHO (1996) Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Division of Control of Tropical Diseases, (WHO/MAL/96.1077) World Health Organization, Geneva.